We use cookies to see how investors use El Fondo and make its tools, data and markets better for you. You can accept or reject; essential cookies always stay on. Privacy Policy
Trades about 55% below its sector, cheaper than its peers on earnings.
Operating out of South Korea, T&L Co., Ltd. specializes in developing and marketing a variety of medical and polymer-based materials. The company's diverse product portfolio features chemical compounds like water-borne resins, hardeners, functional additives, and urethane foam. It also provides a wide array of wound care items, including hydrocolloid, foam, hydrogel, silicone, and alginate dressings. Additionally, T&L manufactures orthopedic goods such as casts and splints. The firm was established in 1998 and maintains its headquarters in Yongin-si, South Korea.
Loading the full price history…
Run your own numbersPast performance is not a forecast.
Save 340570.KQ and get told when something moves.
Get updates
A clear, direct weekly summary.
Learn the fundamentals behind this asset.
A stock is a fraction of ownership in a real company. Buy one share and you own a piece (usually a tiny piece) of every desk, factory, contract and brand the company runs. The price moves because the market keeps revising what that whole pie is worth.
The price-to-earnings ratio is how much investors are paying for one dollar of a company's profit. A multiple, never an absolute. Always compared to something: a sector, a region, the company's own past.
Dividend yield is the annual income a stock or ETF pays out, expressed as a percentage of what you paid for it. It is the visible part of total return: the cash that lands in your account every quarter, and the lever most retail investors actually feel.
Market cap is shares times price. A simple formula that produces wildly unequal numbers: a single US tech name can be worth more than every company on a LATAM exchange combined.
